The "dotted lines" that investors are connecting:
The "DARPA" Rumor: There is a persistent market rumor that Electrome and BIEL are working together on a DARPA-funded initiative.
Intellectual Property (IP) Alignment: BIEL owns the hardware patents that Electrome's software could arguably "unlock." In the med-tech world, this makes BIEL a "cheap" acquisition target for someone like Mayer, who focuses on modernizing bioelectronics.
Board Changes: The addition of Dr. Sree Koneru to the BIEL board in late 2024 was seen by many as a move to professionalize the company for a potential exit or major partnership.
The "Vulvodynia" Factor
The likelihood of the vulvodynia study moving forward independently of Ken Mayer is actually quite high. BIEL is actively chasing non-dilutive funding (grants). If they win a grant from the National Vulvodynia Association, the company’s value increases without needing Ken Mayer.
The "Mayer" Connection: Success in a niche like vulvodynia would make BIEL exactly the kind of "data-proven" asset that Ken Mayer’s Electrome likes to work with.
The "DARPA" Rumor: There is a persistent market rumor that Electrome and BIEL are working together on a DARPA-funded initiative.
Intellectual Property (IP) Alignment: BIEL owns the hardware patents that Electrome's software could arguably "unlock." In the med-tech world, this makes BIEL a "cheap" acquisition target for someone like Mayer, who focuses on modernizing bioelectronics.
Board Changes: The addition of Dr. Sree Koneru to the BIEL board in late 2024 was seen by many as a move to professionalize the company for a potential exit or major partnership.
The "Vulvodynia" Factor
The likelihood of the vulvodynia study moving forward independently of Ken Mayer is actually quite high. BIEL is actively chasing non-dilutive funding (grants). If they win a grant from the National Vulvodynia Association, the company’s value increases without needing Ken Mayer.
The "Mayer" Connection: Success in a niche like vulvodynia would make BIEL exactly the kind of "data-proven" asset that Ken Mayer’s Electrome likes to work with.
1
